olaparib

Ukraine

Drugs containing this active substance

  • LYNPARZA

    The drug is prescribed for the treatment and maintenance therapy of various types of cancer, including ovarian cancer, breast cancer, pancreatic adenocarcinoma, and prostate cancer (in the presence of relevant genetic mutations, such as BRCA1/2).

    Form: tablets, film-coated

    Active substance Dosage
    olaparib 100 mg

    ATC: L01XK01

    Manufacturer: AstraZeneca UK Limited (primary and secondary packaging, quality control, batch release)

  • LYNPARZA

    The drug is prescribed for the treatment and maintenance therapy of various types of cancer, including ovarian cancer, breast cancer, pancreatic adenocarcinoma, and prostate cancer (in the presence of relevant genetic mutations, such as BRCA1/2).

    Form: tablets, film-coated

    Active substance Dosage
    olaparib 150 mg

    ATC: L01XK01

    Manufacturer: AstraZeneca UK Limited (primary and secondary packaging, quality control, batch release)